tradingkey.logo
tradingkey.logo
Search

Curanex Pharmaceuticals Inc

CURX
Add to Watchlist
0.205USD
+0.014+7.43%
Close 07-31 16:00ETQuotes delayed by 15 min
5.82MMarket Cap
LossP/E TTM

CURX Financials

See Curanex Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Curanex Pharmaceuticals Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.11/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.17
-1171.76%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
Financial Indicators
EPS
---0.11
---0.11
---0.04
--0.00
Net Profit
---3.15M
---3.07M
---954.06K
---60.35K
Debt to assets ratio
----
----
----
--50.81%
Operating profit
---3.18M
---3.09M
---951.33K
---57.66K
Net Profit
---3.15M
---3.07M
---954.06K
---60.35K
Current assets
--8.09M
--11.23M
--14.42M
--711.34K
Total current liabilities
--128.73K
--137.03K
--185.96K
--75.93K
Total assets
--8.41M
--11.58M
--14.48M
--787.17K
Total liabilities
--332.64K
--361.04K
--185.96K
--481.74K
Total equity
--8.08M
--11.22M
--14.29M
--305.43K
Net operating income
---954.56K
---857.40K
---9.19M
---290.08K
Net financing
----
--0.00
--14.91M
--200.00K

FAQs

What are the current assets of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its current assets were 11.23M, with a year-on-year change of 2067.74.

What are the total assets of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its total assets of Curanex Pharmaceuticals Inc were 11.58M, with a year-on-year change of 2135.83.

What are the total liabilities of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Curanex Pharmaceuticals Inc were 361.04K, with a year-on-year change of 2377.12.

What is the total equity of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its total equity of Curanex Pharmaceuticals Inc was 11.22M, with a year-on-year change of 2128.84.

What is the net operating income of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Curanex Pharmaceuticals Inc was -4.24M, with a year-on-year change of -1359.81.

What is the net financing of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its net financing of Curanex Pharmaceuticals Inc was 15.31M, with a year-on-year change of 2329.57.

What is the Earnings Per Share (EPS) of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.17, with a year-on-year change of -1171.76.

What is the net income of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its net income was -4.23M, with a year-on-year change of -1068.75.

What is the Return on Equity (ROE) of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -72.09, with a year-on-year change of 43.83.

What is the Return on Assets (ROA) of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -69.85, with a year-on-year change of 42.78.

What is the operating profit of Curanex Pharmaceuticals Inc?

According to Curanex Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -4.24M, with a year-on-year change of -1359.81.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.